BONE CARE INTERNATIONAL INC 4
4 · BONE CARE INTERNATIONAL INC · Filed Jul 5, 2005
Insider Transaction Report
Form 4
Bishop Charles W
EVP - Chief Scientific Officer
Transactions
- Disposition to Issuer
BCII Common Stock
2005-07-01$33.00/sh−100,000$3,300,000→ 0 total - Exercise/Conversion
BCII Stock Option Plan
2005-07-01$8.47/sh−100,000$847,000→ 0 totalExercise: $24.53Exp: 2015-04-25→ BCII Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per share of BCII Common Stock.
- [F2]Each BCII Stock Option became exercisable in full upon consummation of the merger and was cancelled in the merger and was cancelled in the merger in exchange for a cash payment per share subject to the option equal to the difference between the exercise price of the option and $33.00.